Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans

Qureshi AA, Lane RH, Salser AW. Tocotrienols and tocotrienol-like compounds and method for their use. US Patent 5,919,818, 6 July 1999.

Qureshi, 1993, Novel hypercholesterolemic agents with antioxidant properties, 247

Qureshi, 1997, Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans, J. Nutr. Biochem., 8, 290, 10.1016/S0955-2863(97)89667-2

Qureshi, 1991, Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (Palmvitee), Am. J. Clin. Nutr., 53, 1021S, 10.1093/ajcn/53.4.1021S

Qureshi, 1991, Dietary tocotrienols reduce concentrations of plasma cholesterol, apoliprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias, Am. J. Clin. Nutr., 53, 1042S, 10.1093/ajcn/53.4.1042S

Khor, 1995, Tocotrienols inhibit HMG-CoA reductase activity in the guinea pig, Nutr. Res., 15, 537, 10.1016/0271-5317(95)00021-6

Hood, 1992, Effects of guar gum and tocotrienols on cholesterol metabolism on the Japanese quail, Nutr. Res., 12, 117S, 10.1016/S0271-5317(05)80456-7

Watkins, 1993, Tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets, Lipids, 28, 1113, 10.1007/BF02537079

Hood, 1995, Tocotrienols and cholesterol metabolism, 96

Parker, 1993, Tocotrienols regulat cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase, J. Biol. Chem., 268, 11230, 10.1016/S0021-9258(18)82115-9

Qureshi, 1989, Stimulation of avian cholesterol metabolism by α-tocopherol, Nutr. Rep. Int., 40, 993

Qureshi, 1996, Dietary α-tocopherol attenuates the impact of γ-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzymeA reductase activity in chickens, J. Nutr., 126, 389, 10.1093/jn/126.2.389

Qureshi, 2000, Isolation and identification of novel tocotrienols from rice bran with hypocholesterolemic, antioxidant, and antitumor properties, J. Agric. Food Chem., 48, 3130, 10.1021/jf000099t

United States of America, Food & Drug Administration. Tocopherols and derivatives. Proposed affirmation of GRAS status for certain tocopherols and removal of certain others from GRAS status as direct human food ingredients vol. 43 (209, 27 October), 1978. p. 50193–8.

Atroshi, 1992, Palm oil vitamin E effects in hypercholesterolemia, 575

Wahlqvist, 1992, Differential serum responses to tocopherols and tocotrienols during vitamin E supplementation in hypercholesterolemic individuals without change in coronary risk factors, Nutr. Res., 12, 181S, 10.1016/S0271-5317(05)80463-4

Mensink, 1999, A vitamin E concentrate rich in tocotrienols had no effect on serum, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations, Am. J. Clin. Nutr., 69, 213, 10.1093/ajcn/69.2.213

Qureshi, 1995, Response of hypercholesterolemic subjects to administration of tocotrienols, Lipids, 30, 1171, 10.1007/BF02536620

Khor HT, Ng TT. Effects of administration of α-tocopherol and tocotrienols on serum lipids and liver HMG-CoA reductase activity. PORIM International Palm Oil Congress (PIPOC), Nutrition Conference, 1–6 Febuary, 1999. p. 177–86.

Tan, 1991, Effects of palm oil vitamin E concentrate on the serum and lipoprotein lipids of humans, Am. J. Clin. Nutr., 53, 1027S, 10.1093/ajcn/53.4.1027S

Qureshi, 2001, Synergistic effect of tocotrienol rich fraction (TRF25) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans, J. Nutr. Biochem., 12, 318, 10.1016/S0955-2863(01)00144-9

Rationale of the the Diet-Heart Statement of the American Heart Association. Report of the AHA nutrition committee (review). Arteriosclerosis 1982;2:171–91.

National Research Council Committee on Diet and Health. Diet and health: implication of reducing chronic disease risk. Washington DC: National Acedemy of Sciences Press, 1989.

Report of national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. The expert panel. Arch. Int. Med. 1988;148:36–69.

Mevacor (lovastatin, MSD). West Point, Pa: Merck Sharp and Dohme; US package circular, July 1990.

Illingworth, 1988, Drug therapy of hypercholesterolemia, Clin. Chem., 34, 123B

Illingworth, 1987, Lipid-lowering drugs: an overview of indications and optimum therapeutic use, Drugs, 33, 259, 10.2165/00003495-198733030-00003

Kandutsch, 1978, Biological activity of some oxygenated sterols, Science, 201, 498, 10.1126/science.663671

Panini, 1984, Regulation of 3-hydroxy-3-methylglutaryl coenzymeA reductase by oxysterol, by-products of cholesterol biosynthesis, J. Biol. Chem., 259, 7767, 10.1016/S0021-9258(17)42859-6

Nutrition Committee, American Heart Association. Dietary guidelines for healthy American adults. Circulation 1988;77:721-24A.

Kaklon, 1992, Cholesterol-lowering in hamster fed rice bran at various levels, defatted rice bran and rice bran oil, J. Nutr., 122, 513, 10.1093/jn/122.3.513

Hegsted, 1993, Stabilized rice bran and oat bran lower cholesterol in humans, Nutr. Res., 13, 387, 10.1016/S0271-5317(05)80703-1

Kahlon, 1990, Influence of rice bran, oat bran, and wheat bran on cholesterol and trigkycerides in hamsters, Cereal Chem., 67, 439

Seetharamaiah, 1989, Studies of the hypocholesterolemic activity of rice bran, Atherosclerosis, 78, 219, 10.1016/0021-9150(89)90226-8